Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nephrin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nephrin in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(nephrin)
Trials
(nephrin)
Recent Studies (post-2010) (nephrin)
9,1561875521,1309621

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amore, A; Balegno, S; Bussolati, B; Camilla, R; Camussi, G; Coppo, R; Fonsato, V; Loiacono, E; Peruzzi, L; Ricotti, E1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nephrin

ArticleYear
Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes.
    Kidney international, 2010, Volume: 77, Issue:5

    Topics: Adolescent; Adult; Case-Control Studies; Cells, Cultured; Child; Culture Media, Conditioned; Fluorescent Antibody Technique, Indirect; Glycosylation; Humans; Immunoglobulin A; Membrane Proteins; Mesangial Cells; Platelet Activating Factor; Podocytes; Young Adult

2010